前列腺癌外照射放疗准备中水凝胶间隔物渗入髂内静脉并形成血栓一例
本文报道一例前列腺癌外照射放疗准备期间,直肠间隔水凝胶广泛渗入前列腺周围静脉丛,并形成延伸至髂总静脉水平的良性血栓。多学科团队评估了下腔静脉滤器置入与抗凝治疗,患者接受6个月抗凝而未置入滤器,水凝胶与血栓均无症状消退。作者据此回顾事件时间线、症状表现与管理思路,并提出处理范式。
要点
- 直肠间隔水凝胶可发生血管内渗入并伴发良性血栓形成。
- 本例经6个月抗凝、未置入下腔静脉滤器,水凝胶与血栓均无症状消退。
- 直肠间隔物相关毒性(如血管浸润)的最佳管理尚缺乏明确定义。
核心结论
- 直肠间隔水凝胶广泛渗入前列腺周围静脉丛可伴发延伸至髂总静脉水平的良性血栓,经6个月抗凝而未置入下腔静脉滤器后水凝胶与血栓均无症状消退。
研究设计与样本
- 个案报道:一例在前列腺癌外照射放疗准备期间发生水凝胶间隔物渗入髂内静脉并伴血栓形成的患者,由多学科团队评估管理。
主要发现
- 水凝胶广泛渗入前列腺周围静脉丛,并形成延伸至髂总静脉水平的良性血栓。
- 患者经多学科团队评估下腔静脉滤器置入与抗凝治疗。
- 接受6个月抗凝、未置入下腔静脉滤器后,水凝胶与血栓均无症状消退。
临床怎么用
- 对直肠间隔物置入后疑似血管渗入者,可由多学科团队评估抗凝与下腔静脉滤器置入的取舍。
- 本例提示在未置入下腔静脉滤器的情况下,6个月抗凝可使水凝胶与血栓无症状消退,但作者同时提出处理范式,尚需更多数据验证。
局限性
- 为单个病例报道,结论不能外推为普遍管理标准。
- 原文未报告样本量、随访时长等定量数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Use of rectal spacer gel has been associated with decreased risk of radiation therapy (RT)-related rectal toxicity in clinical trials and has been increasingly adopted. Optimal management of spacer-related toxicities, such as rectal wall and vascular infiltration, remains poorly defined. To address this gap, we present a case of extensive hydrogel intravasation of the periprostatic venous plexus with development of associated bland thrombus extending to the level of the common iliac vein. The patient was evaluated for placement of an inferior vena cava (IVC) filter and anticoagulation by a multidisciplinary team. After undergoing 6 months of anticoagulation without IVC filter placement, both the hydrogel and the associated thrombus resolved asymptomatically. We review the timeline of these events, their associated symptomatology, our rationale in management of this clinical scenario, and propose a treatment paradigm.
引用
- Eckstein J, Makary MS, Cataland SR, et al. A Case of Hydrogel Spacer Intravasation of the Internal Iliac Vein and Associated Thrombus Formation During Preparation for Prostate Cancer External Beam Radiation Therapy. Pract Radiat Oncol. 2025. PMID: 40659310. doi:10.1016/j.prro.2025.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。